default author photo

Haoliang He

Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery

SCHOLARLY PAPERS

3

DOWNLOADS

148

TOTAL CITATIONS

0

Scholarly Papers (3)

Chemotherapy Progression Decision Score to Improve Subsequent Treatment Regimens Selection after Initial Assessment for Pancreatic Ductal Adenocarcinoma

Number of pages: 46 Posted: 04 Nov 2025
Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery, Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery, Zhejiang University, Wenzhou Medical University, Zhejiang University, Zhejiang Cancer Hospital, Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery, Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery, Zhejiang University, Zhejiang University, Zhejiang University, Zhejiang University, Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery, Zhejiang University, Huzhou Central Hospital, Chinese Academy of Sciences (CAS) - Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery and Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery
Downloads 51 (1,107,422)

Abstract:

Loading...

pancreatic ductal adenocarcinoma, chemotherapy, treatment regimens selection

Chemotherapy Progression Decision Score to Improve Subsequent Treatment Regimens Selection after Initial Assessment for Pancreatic Ductal Adenocarcinoma

Number of pages: 51 Posted: 27 May 2025
Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery, Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery, Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery, Wenzhou Medical University, Zhejiang University, Zhejiang Cancer Hospital, Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery, Zhejiang University, Zhejiang University, Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery, Zhejiang University, Huzhou Central Hospital, Chinese Academy of Sciences (CAS) - Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery and Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery
Downloads 27 (1,400,723)

Abstract:

Loading...

pancreatic ductal adenocarcinoma, chemotherapy, treatment regimens selection

2.

Ex Vivo Liver Resection and Auto-Transplantation for Cholangiocarcinoma: A Retrospective Cohort Study

Number of pages: 25 Posted: 04 Apr 2025
Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery, Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery, Zhejiang University, Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery, Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery, Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery, Zhejiang University, Zhejiang University, Zhejiang University, Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery, Zhejiang University, Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery and Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery
Downloads 53 (1,031,043)

Abstract:

Loading...

Ex vivo liver resection and auto-transplantation, conventional liver resection, cholangiocarcinoma, vascular invasion, outcome

3.

Gemcitabine-based chemotherapy plus PD-1/PD-L1 inhibitors and tyrosine kinase inhibitors for initially unresectable intrahepatic cholangiocarcinoma: A multicenter, retrospective cohort study

Number of pages: 37 Posted: 08 Jun 2026
Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery, Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery, affiliation not provided to SSRN, Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery, Zhengzhou University, First Affiliated Hospital, Department of Infectious Disease, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Jiaxing University - First Affiliated Hospital, Wenzhou Medical University, Huzhou Central Hospital, China-Japan Friendship Hospital - Department of Hepatobiliary Surgery, Zhejiang University, affiliation not provided to SSRN, Zhejiang Cancer Hospital, Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery, Zhejiang University, affiliation not provided to SSRN, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital, Chinese Academy of Sciences (CAS) - Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery, Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery and Zhejiang University - Department of Hepatobiliary and Pancreatic Surgery
Downloads 17

Abstract:

Loading...

Intrahepatic cholangiocarcinoma, gemcitabine-based chemotherapy, PD-1/PD-L1 inhibitors, tyrosine kinase inhibitors, outcome.